{A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt} | Samar Farid

{A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt}

Citation:: Khattab, N. M., M. Abbassi, H. {A Raafat}, and S. Farid, "{A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt}", Lupus: SAGE Publications Sage UK: London, England, pp. 09612033221083270, 2022.

Abstract:

n/a

Notes:

n/a